| Pharmaceutical active ingredients: |
| Nalbuphine Hydrochloride |
| Available forms, composition and doses of Nalbuphine: |
| Injectable; Injection; Nalbuphine Hydrochloride 10 mg / mlInjectable; Injection; Nalbuphine Hydrochloride 20 mg / ml |
| Nalbuphine medical category: |
| Human:Anaesthetics - local and generalAnalgesics (opioid)Opiate partial agonists |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N02AF02 - Nalbuphine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| AstraZeneca |